Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PTGES | O14684 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.37 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.35 |
| ▸ | GLRB | P48167 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30232599 | 1.00 | HMGCR (0.40) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL3251285 | 0.94 | HMGCR (0.39) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL30232797 | 0.92 | GAA (0.39) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL8954729 | 0.92 | HMGCR (0.46) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL11619679 | 0.91 | HMGCR (0.47) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL29228065 | 0.90 | CYP1A2 (0.45) | HMGCRCYP1A2CYP2C9CYP2C19GLRA3 | |
| SCHEMBL10698399 | 0.89 | VCAM1 (0.38) | HMGCRCYP2C9CYP2C19ALDH1A1CYP2D6 | |
| SCHEMBL2635859 | 0.87 | HMGCR (0.38) | HMGCRCYP1A2CYP2C9CYP2C19PTGES | |
| SCHEMBL671694 | 0.84 | NPSR1 (0.35) | HMGCRPTGESALOX5PPARGMEN1 | |
| SCHEMBL18783187 | 0.84 | GAA (0.37) | HMGCRPTGESALOX5PPARGMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 785 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | claimed |
| US-20250346751-A1 | ACRYLONITRILE STYRENE ACRYLATE COPOLYMER COMPOSITION WITH IMPROVED UV RESISTANCE | INEOS STYROLUTION GROUP GMBH (DE) | 2025-11-13 | — | — | US | claimed |
| US-20240059921-A1 | SCATTERING PARTICLE, INK COMPOSITION INCLUDING THE SAME, AND DISPLAY APPARATUS INCLUDING QUANTUM DOT LAYER PREPARED BY USING THE INK COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-22 | — | — | US | claimed |
| WO-2023202971-A1 | AN AQUEOUS ANTIOXIDANT SUSPOEMULSION AND A PROCESS FOR PREPARING THE SAME | BASF SE (DE) | 2023-10-26 | — | — | WO | claimed |
| CN-114248044-A | Solder composition and electronic substrate | 株式会社田村制作所 | 2022-03-29 | — | — | CN | claimed |
| EP-3426742-B1 | PHOTOCURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF | DOW SILICONES CORP (US) | 2020-02-05 | — | — | EP | claimed |
| EP-3019474-B1 | LIGHT STABILIZERS | BASF SE (DE) | 2019-09-11 | — | — | EP | claimed |
| US-9969864-B2 | Light stabilizers | BASF SE (DE) | 2018-05-15 | — | — | US | claimed |
| EP-2408297-B1 | FORMULATION COMPRISING AVERMECTIN PARTICLES COATED WITH A PHOTO-PROTECTING AGENT | SYNGENTA LTD (GB) | 2016-11-30 | — | — | EP | claimed |
| US-20160168356-A1 | NOVEL LIGHT STABILIZERS | BASF SE (DE) | 2016-06-16 | — | — | US | claimed |
| WO-2010000638-A1 | BLENDS OF STABILIZERS FOR ALIPHATIC POLYESTERS | BASF SE (DE) | 2010-01-07 | — | — | WO | claimed |
| EP-0712887-B2 | Light stable aliphatic thermoplastic urethane elastomers and method of making same | DAVIDSON TEXTRON INC (US) | 2008-08-06 | — | — | EP | claimed |
| EP-1925628-A1 | Process for polyolefin silane crosslinking | Ciba Holding Inc. (CH) | 2008-05-28 | — | — | EP | claimed |
| JP-2007510767-A | — | — | 2007-04-26 | — | — | JP | claimed |
| US-20070027243-A1 | Stabilizer compositions for halogen containing polymers | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-01 | — | — | US | claimed |
| EP-1680463-A2 | STABILIZER COMPOSITIONS FOR HALOGEN CONTAINING POLYMERS | Ciba SC Holding AG (CH) | 2006-07-19 | — | — | EP | claimed |
| WO-2005049715-A2 | STABILIZER COMPOSITIONS FOR HALOGEN CONTAINING POLYMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-06-02 | — | — | WO | claimed |
| EP-0818526-B1 | Stabilizers for the prevention of gum formation in gasoline | CIBA SC HOLDING AG (CH) | 2003-02-12 | — | — | EP | claimed |
| EP-0712887-B1 | Light stable aliphatic thermoplastic urethane elastomers and method of making same | DAVIDSON TEXTRON INC (US) | 2000-05-17 | — | — | EP | claimed |
| EP-0573393-B1 | Perfluoroalkyl substituted hydroxyphenylalkanoic ester antioxidants | CIBA GEIGY AG (CH) | 1995-12-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168356-A1 | NOVEL LIGHT STABILIZERS | QDPR, CRY1, CRYZ | HMGCR 3913/4885CYP1A2 2389/4885CYP2C9 3083/4885 |
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | IK, INCENP, TYR | HMGCR 4730/4885CYP1A2 438/4885CYP2C9 925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.